drugset / Trial / NCT01690052

Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva

NCT01690052

Completed 15 enrolled University of Kentucky
RandomizedCrossoverDouble-blindTreatment

Summary

The main objectives were: 1) To determine the efficacy of both cevimeline and pilocarpine in the secretion of saliva in patients with xerostomia, and 2) To compare the side-effects between the treatment for xerostomia with cevimeline and with pilocarpine.

Timeline

Start
2009-01
Primary completion
2010-06
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cevimeline Small molecule 30 mg
Comparator Pilocarpine Unknown 5 mg

Indications

No indication recorded.